Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex

J Infect. 1998 Jan;36(1):113-5. doi: 10.1016/s0163-4453(98)93522-8.

Abstract

Coccidioidomycosis is endemic in regions of the Americas, but this infection may be encountered in travellers who return from an endemic region. A case is reported of a disseminated infection in a Hong Kong Chinese man, who was successfully treated with amphotericin B lipid complex (ABLC) after intolerance and toxicity precluded the use of other antifungal agents. Lipid-based formulations of amphotericin B merit further evaluation in the treatment of coccidioidomycosis and other systemic mycoses.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Coccidioidomycosis / drug therapy*
  • Coccidioidomycosis / transmission
  • Drug Combinations
  • Humans
  • Male
  • Phosphatidylcholines / therapeutic use*
  • Phosphatidylglycerols / therapeutic use*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Drug Combinations
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • liposomal amphotericin B
  • Amphotericin B